Roth Capital Resumes Natus Medical (BABY) at Buy, Says Selloff is Buying Opportunity
Tweet Send to a Friend
Roth Capital resumes coverage on Natus Medical (NASDAQ: BABY) with a Buy rating and a price target of $39.00.Analyst Scott ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
